A
AmpliMed Corporation
AmpliMed Home, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
About AmpliMed Corporation
In 2014, Brazilian brothers Darlan and Liandro Segalin founded Amplimed to improve clinical work and the patient experience. A year later, in 2015, they launched their cloud-based software platform designed for managing medical clinics and offices. The goal was to create a complete solution for healthcare management in Brazil. The platform offers features like electronic health records, telemedicine capabilities, appointment scheduling, and financial management tools. In 2017, the company brought on a new partner, physician Dr. Marcos André Sonagli, to help refine the products and services with a practitioner's perspective. This addition helped the company enhance its offerings, which include specialized modules for different medical fields, such as dermatology and pediatrics. The following year, Amplimed received a boost through the accelerator/incubator Oxigenio Aceleradora, which helped fuel its early growth. A significant turning point for Amplimed came in December 2021 when it was acquired by Raia Drogasil, a major player in the Brazilian pharmacy market. This acquisition integrated Amplimed into a larger healthcare ecosystem, connecting clinics, labs, hospitals, and now pharmacies. The move aimed to create a more connected digital health landscape in Brazil, with Amplimed as a key component.
Source: Dealroom company dataNews
Open roles
AmpliMed Corporation in the Tucson ecosystem
The AmpliMed Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- VVValley Ventures
- SCSolstice Capital
Village Ventures
Series B and later1 investor entered at this stage
BioMed Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AmpliMed Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AmpliMed Corporation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

